Literature DB >> 32151175

MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.

Yanhua Yang1, Shujun Xia2, Lu Zhang2, Wenhan Wang2, Lin Chen2,3, Weiwei Zhan2.   

Abstract

MiR-324-5p is overexpressed in papillary thyroid carcinoma (PTC) with lymph node metastasis and promotes malignant phenotypes of KTC-1 cell line. However, the detailed regulatory mechanism remains unknown. Tumor microenvironment plays a key role in tumor progression. CCAAT enhancer-binding protein delta (CEBPD) is important in immune and inflammatory responses. In this study, we investigated the interaction between miR-324-5p/PTPRD/CEBPD axis and tumor microenvironment in PTC progression. K1 and KTC-1 were transfected by lenti-CEBPD or CEBPD-sh vectors. Supernatant from different groups was harvested and added into culture media of human macrophages and HUVEC. Cell viability, colony formation, invasive and migrated cell number, and gap closure rate were elevated in lenti-CEBPD group. Compared with the control, supernatant from lenti-CEBPD group contained more abundant levels of VEGF and IL-4/IL-13, which, respectively, induced higher HUVEC invasion/migration rates and more obvious M2 marker (CD206) and genes (PPAR-γ and MRC-1) expression in macrophages. By means of luciferase reporter assay and gene manipulation, we identified that CEBPD was negatively regulated in PTC by protein tyrosine phosphatase receptor delta (PTPRD) which was the target of miR-324-5p. CEBPD-shRNA was also proved to reverse the effect of PTPRD-sh1 or miR-324-5p mimic on IL-4/IL-13 expression and HUVEC invasion. These results suggested that miR-324-5p/PTPRD/CEBPD axis was involved in the progression of PTC by inducing HUVEC invasion/migration and macrophage M2 polarization via VEGF and IL4/IL13, respectively.

Entities:  

Keywords:  CCAAT enhancer binding protein delta; Tumor microenvironment; miR-324-5p; papillary thyroid carcinoma; progression

Mesh:

Substances:

Year:  2020        PMID: 32151175      PMCID: PMC7515492          DOI: 10.1080/15384047.2020.1736465

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  31 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 3.  Tumor microenvironment: Sanctuary of the devil.

Authors:  Lanlan Hui; Ye Chen
Journal:  Cancer Lett       Date:  2015-08-11       Impact factor: 8.679

Review 4.  The chemokine system in diverse forms of macrophage activation and polarization.

Authors:  Alberto Mantovani; Antonio Sica; Silvano Sozzani; Paola Allavena; Annunciata Vecchi; Massimo Locati
Journal:  Trends Immunol       Date:  2004-12       Impact factor: 16.687

Review 5.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 6.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

7.  Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers.

Authors:  Jae Won Cho; Won Woong Kim; Yu-Mi Lee; Min Ji Jeon; Won Gu Kim; Dong Eun Song; Yangsoon Park; Ki-Wook Chung; Suck Joon Hong; Tae-Yon Sung
Journal:  Head Neck       Date:  2019-01-19       Impact factor: 3.147

8.  Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.

Authors:  Mabel Ryder; Ronald A Ghossein; Julio C M Ricarte-Filho; Jeffrey A Knauf; James A Fagin
Journal:  Endocr Relat Cancer       Date:  2008-08-21       Impact factor: 5.678

9.  Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer.

Authors:  Yuan Chen; Shao-Xin Wang; Rui Mu; Xue Luo; Zhao-Shan Liu; Bing Liang; Hai-Long Zhuo; Xiao-Peng Hao; Qiong Wang; Di-Feng Fang; Zhao-Fang Bai; Qian-Yi Wang; He-Mei Wang; Bao-Feng Jin; Wei-Li Gong; Tao Zhou; Xue-Min Zhang; Qing Xia; Tao Li
Journal:  Cell Rep       Date:  2014-05-29       Impact factor: 9.423

10.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

View more
  8 in total

Review 1.  Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer.

Authors:  Qi Liu; Wei Sun; Hao Zhang
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

2.  Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro.

Authors:  Weiyang Lou; Bisha Ding; Shuqian Wang; Peifen Fu
Journal:  Cancer Cell Int       Date:  2020-08-06       Impact factor: 5.722

3.  LncRNA HCG18 facilitates melanoma progression by modulating miR-324-5p/CDK16 axis.

Authors:  Chengwei Zhang; Haitao Lv; Fengling Zhang; Aihua Ji
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

4.  A crosstalk between type 2 innate lymphoid cells and alternative macrophages in lung development and lung diseases (Review).

Authors:  Lan-Lan Mi; Yue Zhu; Hong-Yan Lu
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

5.  Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke Qiu; Yao Song; Yufang Rao; Qiurui Liu; Danni Cheng; Wendu Pang; Jianjun Ren; Yu Zhao
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

6.  Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis.

Authors:  Hualin Sun; Ming Li; Yanan Ji; Jianwei Zhu; Zehao Chen; Lilei Zhang; Chunyan Deng; Qiong Cheng; Wei Wang; Yuntian Shen; Dingding Shen
Journal:  Antioxidants (Basel)       Date:  2022-02-01

Review 7.  A review on the role of miRNA-324 in various diseases.

Authors:  Sepideh Kadkhoda; Bashdar Mahmud Hussen; Solat Eslami; Soudeh Ghafouri-Fard
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

8.  microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C.

Authors:  Y Wang; H Ye; Y Yang; J Li; A Cen; L Zhao
Journal:  J Endocrinol Invest       Date:  2021-06-18       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.